Know Cancer

or
forgot password

Topical Treatment With Glucocorticoids to Prevent Hypertrophic Scars and Keloid Due to Central Venous Access in Children


Phase 3
N/A
21 Years
Open (Enrolling)
Both
Hypertrophic Scars, Keloids

Thank you

Trial Information

Topical Treatment With Glucocorticoids to Prevent Hypertrophic Scars and Keloid Due to Central Venous Access in Children


Inclusion Criteria:



- All children and adolescents who have a central venous catheter removed at the
Childrens Department of Oncology at Aarhus University Hospital Skejby in the period
from March 2010 to July 2011

Exclusion Criteria:

- Known allergy towards plaster or fusidic acid

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Outcome Measure:

scars measured by the Vancouver Scar Scale twelve months after central venous catheter removal

Outcome Time Frame:

Twelve months

Safety Issue:

No

Principal Investigator

Henrik Hasle, Professor

Investigator Role:

Principal Investigator

Investigator Affiliation:

Aarhus University Hospital Skejby

Authority:

Denmark: The Danish National Committee on Biomedical Research Ethics

Study ID:

2009-015163-14

NCT ID:

NCT01113125

Start Date:

March 2010

Completion Date:

July 2016

Related Keywords:

  • Hypertrophic Scars
  • Keloids
  • hypertrophic scar
  • keloid
  • central venous catheter
  • children
  • cancer
  • Hypertrophy
  • Keloid
  • Cicatrix, Hypertrophic
  • Cicatrix

Name

Location